June 30, 2021
Chugai Pharmaceutical said on June 29 that it has filed a new drug application for a COVID-19 antibody cocktail of casirivimab and imdevimab, originated by Regeneron Pharmaceuticals, seeking its exceptional approval in Japan. The submission rides on the back of...read more